Annenberg Center for Health Sciences At Eisenhower

Out interprofessional faculty share their real-world experience as they discuss the etiology, diagnosis, staging, and treatment of patients with neurotrophic keratitis. In addition to an overview of symptomatic care and emerging treatments, the safety, efficacy, storage, and administration of cenegermin are explained in detail. Clinical and real-world questions are discussed, related to patient education, provided by the interprofessional, multidisciplinary team.
https://annenberg.net/courses/landingPage.php?courseID=60880

Join Mary Kay Koenig, MD, in this free CME activity as she explains TK2d's clinical presentation through real case studies. Dr. Koenig offers guidance on diagnosing mitochondrial diseases, discusses the criteria for referring patients to specialized mitochondrial centers, explores vital aspects of supportive care, and shares insights into a novel therapy providing hope for the future of TK2d treatment. Don't miss this invaluable opportunity to enhance your knowledge and practice.
https://annenberg.net/courses/landingPage.php?courseID=60530

Annenberg Center for Health Sciences Mary Kay Koenig, MD, a leader in the management of patients with mitochondrial diseases, delves into the complexities of managing patients with thymidine kinase 2 deficiency (TK2d). In this 1-hour activity, Dr. Koenig shares her insights in the clinical presentation of TK2d through real case studies...

📢 Exciting Announcement! Join us for a free LIVE CE Webcast on Wednesday, June 12th!

Our expert faculty will provide insights on:
✅ Guidelines for complementary feeding
✅ Early allergen introduction for food allergy prevention
✅ Best practices & clinical considerations for early introduction of allergenic foods
✅ Utilizing allergenic foods to enhance diversity during complementary feeding

https://pnce.org/courses/landingPage.php?courseID=6079-IL

Please join cardiologist Jorge Plutzy, MD,and endocrinologist Helena Rodbard, MD as they navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease. In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. The faculty also provide recommendations to optimize the use of GLP-1RAs as a class, as well as individually, including strategies to mitigate gastrointestinal adverse events and address patient concerns.
https://annenberg.net/courses/landingPage.php?courseID=60520

We are pleased to offer the following Allergy Presentations this month:

- How to Use Phenotyping to Guide Management of Food Allergy
- Food Allergy Tests Are Not Screening Tests
- Social Media For Clinicians Who Care For Infants
- Instilling Confidence Surrounding Early Introduction of Allergenic Foods
- Food Oral Immunotherapy
- Tackling Allergy Misinformation
- Exploring the Connection Between the Microbiome and Allergy Development

https://pnce.org/Allergy2024

Join us tomorrow for the symposium, "Emerging Developments in Human Milk Fortification: Problem Solving for Clinical Practice."

-Overcoming challenges to optimal preterm infant nutrition
-Strategic use of donor milk
-Human milk fortification timing and clinical practice strategies
-Influence of feeding types on the preterm microbiome
-Emerging evidence on human milk bioactives

https://pnce.org/toronto

Discover the intricacies of metabolic dysfunction-associated steatohepatitis (MASH). Join us for a deep dive into this critical topic with a 1-hour journal-style review, complete with insightful videos from expert faculty Drs. Jay Shubrook and Arun Sanyal. They'll share their invaluable insights on the identification, diagnosis, and treatment of MASH in primary care.

https://annenberg.net/courses/landingPage.php?courseID=60571

The landscape of Chronic Lymphocytic Leukemia (CLL) treatment has undergone a profound transformation with the advent of targeted therapies. Discover the power of utilizing Minimal Residual Disease (MRD) as a treatment response indicator and prognostic marker.

Join our 1-hour online, self-directed activity to embark on a journey through 9 complex real-world clinical decisions. This unique educational experience is designed to actively engage clinicians, advancing their understanding and application of the best evidence and practices in CLL management.

Don't miss this opportunity to elevate your expertise and contribute to the positive transformation in CLL care!

https://annenberg.net/courses/landingPage.php?courseID=60750

Join us in Toronto for the symposium, "Emerging Developments in Human Milk Fortification: Problem Solving for Clinical Practice."

-Overcoming challenges to optimal preterm infant nutrition
-Strategic use of donor milk
-Human milk fortification timing and clinical practice strategies
-Influence of feeding types on the preterm microbiome
-Emerging evidence on human milk bioactives

https://pnce.org/toronto

Survival outcomes for advanced cholangiocarcinoma remain suboptimal, despite first-line treatment with cytotoxic chemotherapy. A greater understanding of cholangiocarcinoma's pathobiology has illuminated various treatment targets, leading to several treatment advances. In this CE acitvity, medical oncologist Lipika Goyal, MD, MPhil, discusses key concepts in navigating through the selection and use of these agents, including managing associated adverse events, helping shape the management of advanced cholangiocarcinoma to optimize patient care.
https://annenberg.net/courses/landingPage.php?courseID=60480

Dive into the world of Neuromyelitis Optica Spectrum Disorder (NMOSD) with Michael Levy, MD, a leading neuroimmunologist at Massachusetts General Hospital. Join us for a concise yet comprehensive 45-minute educational session where Dr. Levy covers NMOSD pathogenesis, diagnosis criteria, laboratory testing, imaging, and common misdiagnoses. Additionally, he discusses the safety and efficacy of approved and off-label therapy options, offering valuable insights for tailoring treatment plans to suit the unique needs of NMOSD patients.
https://annenberg.net/courses/landingPage.php?courseID=60600

Join us for a dynamic 1.5-hour online CE course featuring an interprofessional team of primary care and specialty clinicians who discuss real-world challenges in managing patients with complex dyslipidemia, including elevated lipoprotein a (Lp(a)).

Dive into insightful paired conversations as our expert faculty explore recent cholesterol guidelines, patient risk stratification, and recommended goals for those at risk of atherosclerotic cardiovascular disease.

This program format is designed to foster critical thinking and the application of key concepts to real patient cases, empowering participants to elevate their clinical practice.

https://annenberg.net/courses/landingPage.php?courseID=60560

Jason J. Luke, MD, discusses the impact of evolving therapies on the disease burden, survival, and treatment tolerability for patients with cutaneous melanoma. Recent clinical trial results and guideline updates for both perioperative and metastatic cutaneous melanoma are reviewed. To provide patient-centric care, Dr. Luke shares his expert insights and recommendations for individualizing treatment selection and sequencing, as well as providing supportive care and adverse event management. https://annenberg.net/courses/landingPage.php?courseID=60620

Exploring the intricacies of follicular lymphoma, a subtype of non-Hodgkin lymphoma, Jeremy Abramson, MD, delves into the challenges faced by patients and healthcare providers alike. From relapses to multiple lines of therapy, this 1-hour online CE course promises insights into the significant disease burden and the latest advancements in treatment options. Additonally, Dr. Abramson discusses the interprofessional care team approach. Join the conversation and be part of the solution!
https://annenberg.net/courses/landingPage.php?courseID=60650